Clinical Trial Update: Hepatitis B Vaccine Delivered Trans-dermally by MAP [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial evaluating a trans-dermal Hepatitis B vaccine delivered via a MAP patch. Recruitment has not yet begun.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Trans-dermal MAP Hepatitis B vaccine

Snippet

Sponsor: International Vaccine Institute | Conditions: Hepatitis B Vaccine | Phase 1 | Status: NOT_YET_RECRUITING